Afatinib in Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations Pretreated With Reversible EGFR Inhibitors

Por Heigener, David F., Schumann, Christian, Sebastian, Martin, Sadjadian, Parvis, Stehle, Ingo, Märten, Angela, Lüers, Anne, Griesinger, Frank, Scheffler, Matthias
Publicado no Oncologist (2015)

Benefit-risk profile of cytoreductive drugs along with antiplatelet and antithrombotic therapy after transient ischemic attack or ischemic stroke in myeloproliferative neoplasms

Por De Stefano, Valerio, Carobbio, Alessandra, Di Lazzaro, Vincenzo, Guglielmelli, Paola, Iurlo, Alessandra, Finazzi, Maria Chiara, Rumi, Elisa, Cervantes, Francisco, Elli, Elena Maria, Randi, Maria Luigia, Griesshammer, Martin, Palandri, Francesca, Bonifacio, Massimiliano, Hernandez-Boluda, Juan-Carlos, Cacciola, Rossella, Miroslava, Palova, Carli, Giuseppe, Beggiato, Eloise, Ellis, Martin H., Musolino, Caterina, Gaidano, Gianluca, Rapezzi, Davide, Tieghi, Alessia, Lunghi, Francesca, Loscocco, Giuseppe Gaetano, Cattaneo, Daniele, Cortelezzi, Agostino, Betti, Silvia, Rossi, Elena, Finazzi, Guido, Censori, Bruno, Cazzola, Mario, Bellini, Marta, Arellano-Rodrigo, Eduardo, Bertozzi, Irene, Sadjadian, Parvis, Vianelli, Nicola, Scaffidi, Luigi, Gomez, Montse, Cacciola, Emma, Vannucchi, Alessandro M., Barbui, Tiziano
Publicado no Blood Cancer J (2018)